These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22033235)

  • 1. Timed short messaging service improves adherence and virological outcomes in HIV-1-infected patients with suboptimal adherence to antiretroviral therapy.
    Ammassari A; Trotta MP; Shalev N; Tettoni MC; Maschi S; Di Sora F; Orofino G; d'Ettorre G; Bai F; Celesia MB; Quiros Roldan E; Maserati R; Sterrantino G; Tommasi C; Boumis E; Iardino MR; Antinori A
    J Acquir Immune Defic Syndr; 2011 Dec; 58(4):e113-5. PubMed ID: 22033235
    [No Abstract]   [Full Text] [Related]  

  • 2. Acceptability and factors associated with willingness to receive short messages for improving antiretroviral therapy adherence in China.
    Xiao Y; Ji G; Tian C; Li H; Biao W; Hu Z
    AIDS Care; 2014; 26(8):952-8. PubMed ID: 24359520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies.
    Braithwaite RS; Kozal MJ; Chang CC; Roberts MS; Fultz SL; Goetz MB; Gibert C; Rodriguez-Barradas M; Mole L; Justice AC
    AIDS; 2007 Jul; 21(12):1579-89. PubMed ID: 17630553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with suboptimal antiretroviral therapy adherence to dose, schedule, and dietary instructions.
    Nilsson Schönnesson L; Williams ML; Ross MW; Bratt G; Keel B
    AIDS Behav; 2007 Mar; 11(2):175-83. PubMed ID: 16927178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of adherence to antiretroviral therapy in sub-Saharan African native HIV-infected patients in France and Africa.
    Sellier P; Clevenbergh P; Ljubicic L; Simoneau G; Evans J; Delcey V; Diemer M; Bendenoun M; Mouly S; Bergmann JF
    Clin Infect Dis; 2006 Sep; 43(5):654-7. PubMed ID: 16886162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to antiretroviral therapy--achievable in the South African context?
    Orrell C; Bekker LG; Wood R
    S Afr Med J; 2001 Jun; 91(6):483-4. PubMed ID: 11455708
    [No Abstract]   [Full Text] [Related]  

  • 7. Virological Outcome of Patients With HIV Drug Resistance Attending an Urban Outpatient Clinic in Uganda: A Need for Structured Adherence Counseling and Third-Line Treatment Options.
    Baumann A; Musaazi J; Kambugu A; Kälin M; Weissberg D; Ssemwanga D; Fehr J; Castelnuovo B; Sekaggya-Wiltshire C; von Braun A
    J Acquir Immune Defic Syndr; 2019 Apr; 80(4):481-487. PubMed ID: 30633041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with adherence to antiretroviral therapy among HIV/AIDS patients in rural China.
    Wang X; Wu Z
    AIDS; 2007 Dec; 21 Suppl 8():S149-55. PubMed ID: 18172384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral adherence and virological outcomes in HIV-positive patients in Ugu district, KwaZulu-Natal province.
    Kapiamba G; Masango T; Mphuthi D
    Afr J AIDS Res; 2016 Sep; 15(3):195-201. PubMed ID: 27681144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combination SMS and transportation reimbursement intervention to improve HIV care following abnormal CD4 test results in rural Uganda: a prospective observational cohort study.
    Siedner MJ; Santorino D; Lankowski AJ; Kanyesigye M; Bwana MB; Haberer JE; Bangsberg DR
    BMC Med; 2015 Jul; 13():160. PubMed ID: 26149722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence and treatment response among HIV-1-infected adults receiving antiretroviral therapy in a rural government hospital in Southwestern Uganda.
    Bajunirwe F; Arts EJ; Tisch DJ; King CH; Debanne SM; Sethi AK
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(2):139-47. PubMed ID: 19258526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to antiretroviral therapy in HIV patients with psychiatric comorbidity.
    De Socio GV; Fanelli L; Longo A; Stagni G
    J Acquir Immune Defic Syndr; 2004 Aug; 36(5):1109-10. PubMed ID: 15247568
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving adherence to antiretroviral therapy.
    Daar ES; Cohen C; Remien R; Sherer R; Smith K
    AIDS Read; 2003 Feb; 13(2):81-2, 85-6, 88-90. PubMed ID: 12645492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome.
    Walsh JC; Mandalia S; Gazzard BG
    AIDS; 2002 Jan; 16(2):269-77. PubMed ID: 11807312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence over 48 weeks in an antiretroviral clinical trial: variable within patients, affected by toxicities and independently predictive of virological response.
    Nieuwkerk P; Gisolf E; Sprangers M; Danner S;
    Antivir Ther; 2001 Jun; 6(2):97-103. PubMed ID: 11491422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifetime HIV antiretroviral therapy adherence intervention: timing is everything: comment on "Managed problem solving for antiretroviral therapy adherence".
    Bangsberg DR; Haberer JE
    JAMA Intern Med; 2013 Feb; 173(4):306-7. PubMed ID: 23358810
    [No Abstract]   [Full Text] [Related]  

  • 17. The information-motivation-behavioral skills model of antiretroviral adherence and its applications.
    Fisher JD; Amico KR; Fisher WA; Harman JJ
    Curr HIV/AIDS Rep; 2008 Nov; 5(4):193-203. PubMed ID: 18838059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower perceived necessity of HAART predicts lower treatment adherence and worse virological response in the ATHENA cohort.
    de Boer-van der Kolk IM; Sprangers MA; van der Ende M; Schreij G; de Wolf F; Nieuwkerk PT
    J Acquir Immune Defic Syndr; 2008 Dec; 49(4):460-2. PubMed ID: 19011424
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of Mother-Infant Pair Clinics and Short-Text Messaging Service (SMS) Reminders on Retention of HIV-Infected Women and HIV-Exposed Infants in eMTCT Care in Malawi: A Cluster Randomized Trial.
    Mwapasa V; Joseph J; Tchereni T; Jousset A; Gunda A
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S123-S131. PubMed ID: 28498181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot RCT of bidirectional text messaging for ART adherence among nonurban substance users with HIV.
    Ingersoll KS; Dillingham RA; Hettema JE; Conaway M; Freeman J; Reynolds G; Hosseinbor S
    Health Psychol; 2015 Dec; 34S(0):1305-15. PubMed ID: 26651472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.